{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:17:52Z","timestamp":1773778672393,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e29469","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T12:30:09Z","timestamp":1712665809000},"page":"e29469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of MEFV gene variants, IL-33, and sST2 with the risk of Henoch-Sch\u00f6nlein purpura in children"],"prefix":"10.1016","volume":"10","author":[{"given":"Yang","family":"Ruan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5690-9083","authenticated-orcid":false,"given":"Longlong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e29469_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/art.40375","article-title":"Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"70","author":"Sunderk\u00f6tter","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000185813","article-title":"Henoch-Sch\u00f6nlein purpura and IgA nephropathy in father and son","volume":"54","author":"Montoliu","year":"1990","journal-title":"Nephron"},{"key":"10.1016\/j.heliyon.2024.e29469_bib3","article-title":"IgA vasculitis update: epidemiology, pathogenesis, and biomarkers","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","author":"Consortium","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2024.e29469_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ng1101-241","article-title":"A fever gene comes in from the cold","volume":"29","author":"Kastner","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2024.e29469_bib6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00296-011-1840-z","article-title":"Coexistence of vasculitides with familial Mediterranean fever","volume":"31","author":"Aksu","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.heliyon.2024.e29469_bib7","first-page":"517","article-title":"IL-33 and sST2 levels in serum of children with henoch- Sch\u00f6nlein purpura and their clinical significance","volume":"25","author":"Wang","year":"2017","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.heliyon.2024.e29469_bib8","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s00296-011-2266-3","article-title":"Investigation of the change in CD4+ T cell subset in children with Henoch-Schonlein purpura","volume":"32","author":"Li","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.heliyon.2024.e29469_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12887-019-1802-2","article-title":"Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Sch\u00f6nlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Sch\u00f6nlein purpura with gastrointestinal involvement in children","volume":"19","author":"Zhu","year":"2019","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.heliyon.2024.e29469_bib10","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.3390\/ijms22147538","article-title":"IgA vasculitis: etiology, treatment, biomarkers and epigenetic changes","volume":"22","author":"Sugino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e29469_bib11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188718","article-title":"HSPrognosis group, Biomarkers of IgA vasculitis nephritis in children","volume":"12","author":"Pillebout","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e29469_bib13","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.21037\/apm-21-1227","article-title":"The changes in pyroptosis-related inflammatory factors in the peripheral blood of patients with Henoch-Schonlein purpura","volume":"10","author":"Wang","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.heliyon.2024.e29469_bib14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in tissue homeostasis, injury, and inflammation","volume":"42","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2024.e29469_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2024.e29469_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2020.04.011","article-title":"Soluble ST2: a complex and diverse role in several diseases","volume":"507","author":"Homsak","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2024.e29469_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/annrheumdis-2011-200589","article-title":"IL-33: a Janus cytokine","volume":"71","author":"Liew","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e29469_bib18","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2310\/JIM.0b013e31826d8fcb","article-title":"IL-33: a potential therapeutic target in autoimmune diseases","volume":"60","author":"Wang","year":"2012","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.heliyon.2024.e29469_bib19","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/annrheumdis-2012-203187","article-title":"Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome","volume":"73","author":"Awada","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e29469_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3899\/jrheum.140234","article-title":"The Interleukin 33\/ST2 axis in patients with primary Sjogren syndrome: expression in serum and salivary glands and the clinical association","volume":"42","author":"Jung","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib21","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3899\/jrheum.080405","article-title":"MEFV mutations modify the clinical presentation of Henoch-Sch\u00f6nlein purpura","volume":"35","author":"Oz\u00e7akar","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1651-2227.2011.02143.x","article-title":"Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch-Sch\u00f6nlein purpura","volume":"100","author":"Bayram","year":"2011","journal-title":"Acta. Pediatr."},{"key":"10.1016\/j.heliyon.2024.e29469_bib23","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00467-010-1582-2","article-title":"MEFV E148Q polymorphism is associated with Henoch-Sch\u00f6nlein purpura in Chinese children","volume":"25","author":"He","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00296-016-3596-y","article-title":"The association between MEFV gene polymorphisms and Henoch-Sch\u00f6nlein purpura, and additional SNP-SNP interactions in Chinese Han children","volume":"37","author":"Xiong","year":"2017","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.heliyon.2024.e29469_bib25","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.2005.046300","article-title":"EULAR\/PReS endorsed consensus criteria for the classification of childhood vasculitides","volume":"65","author":"Ozen","year":"2006","journal-title":"Annals of the rheumatic dieases"},{"key":"10.1016\/j.heliyon.2024.e29469_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00281-021-00874-9","article-title":"IgA vasculitis","volume":"43","author":"Pillebout","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib27","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.autrev.2017.10.009","article-title":"New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura)","volume":"16","author":"Heineke","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.heliyon.2024.e29469_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/00325481.2019.1552479","article-title":"MEFV gene variants in children with Henoch-Schonlein purpura and association with clinical manifestations: a single-center Mediterranean experience","volume":"131","author":"Ekinci","year":"2019","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.heliyon.2024.e29469_bib29","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10067-019-04489-2","article-title":"MEFV gene mutations in children with Henoch-Schonlein purpura and their correlations-do mutations matter?","volume":"38","author":"Cakici","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib30","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3906\/sag-1505-131","article-title":"MEFV gene in Ira nian Azari Turkish patients with Henoch-Schonlein purpura","volume":"46","author":"Bonyadi","year":"2016","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.heliyon.2024.e29469_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1546-0096-12-41","article-title":"MEFV gene mutations in Egyptjan children with Henoch-schonlein purpura","volume":"12","author":"Salah","year":"2014","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.heliyon.2024.e29469_bib32","first-page":"e385","article-title":"MEFV gene mutations and clinical course in pediatric patients with Henoch-Sch\u00f6nlein purpura","volume":"116","author":"Can","year":"2018","journal-title":"Arch. Argent. Pediatr."},{"key":"10.1016\/j.heliyon.2024.e29469_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1098-1004(200004)15:4<385::AID-HUMU22>3.0.CO;2-A","article-title":"The E148Q mutation in the MEFV gene: is it a diseasecausing mutation or a sequence variant?","volume":"15","author":"Ben-Chetrit","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.heliyon.2024.e29469_bib34","first-page":"1091","article-title":"MEFV mutations in Japanese rheumatoid arthritis patients","volume":"26","author":"Migita","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib35","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jbspin.2008.09.011","article-title":"Clinical significance of MEFV mutations in ankylosing spondylitis","volume":"76","author":"Durmus","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.heliyon.2024.e29469_bib36","first-page":"84","article-title":"MEFV gene mutations (M694V, V726A, M680I, and A744S) in Iranian children with Henoch-Schonlein purpura","volume":"61","author":"Nikibakhsh","year":"2012","journal-title":"Pneumologia"},{"key":"10.1016\/j.heliyon.2024.e29469_bib37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1067\/S0022-3476(03)00502-X","article-title":"Prevalence and significance of mutation in familial Mediterranean fever gene in Henoch-Sch\u00f6nlein purpura","volume":"143","author":"Gershoni-Baruch","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.heliyon.2024.e29469_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/1756-185X.12072","article-title":"MEFV gene mutations in Henoch- Sch\u00f6nlein purpura","volume":"16","author":"Altug","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.heliyon.2024.e29469_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s13075-014-0439-7","article-title":"Genotypephenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations","volume":"16","author":"Kishida","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.heliyon.2024.e29469_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172975","article-title":"A dominant pathogenic MEFV mutation causes atypical pyrin-associated periodic syndromes","volume":"8","author":"Wang","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.heliyon.2024.e29469_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.ejhg.5200608","article-title":"A single mutated MEFV allele in Israeli patients suffering from Familial Mediterranean Fever and Behcet's disease (FMF-BD)","volume":"9","author":"Livneh","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.heliyon.2024.e29469_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.06.010","article-title":"Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review","volume":"103","author":"Shin","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.heliyon.2024.e29469_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2023.03.024","article-title":"Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS)-NRF2-Heme oxygenase-1(HO-1)-NF-\u043aB axis","volume":"202","author":"Zeng","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e29469_bib44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41419-021-04159-9","article-title":"A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis","volume":"12","author":"Zheng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e29469_bib45","first-page":"16000","article-title":"Serum Interleukin-33 level in Saudi children with inflammatory bowel disease","volume":"8","author":"Saadah","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib46","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/ard.2009.122655","article-title":"IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy","volume":"69","author":"Verri","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e29469_bib47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fimmu.2012.00082","article-title":"Mast cells respond to cell injury through the recognition of IL-33","volume":"3","author":"Lunderius-Andersson","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cytogfr.2015.07.017","article-title":"The IL-33\/ST2 axis: role in health and disease","volume":"26","author":"De la Fuente","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.heliyon.2024.e29469_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00403-012-1268-7","article-title":"Elevated serum interleukin-33 levels in patients with Henoch-Schonlein purpura","volume":"305","author":"Chen","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.heliyon.2024.e29469_bib52","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","article-title":"Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production","volume":"114","author":"Choi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e29469_bib53","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1073\/pnas.1418549112","article-title":"T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses","volume":"112","author":"Baumann","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2024.e29469_bib54","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2018.01.034","article-title":"Mast cells signal their importance in health and disease","volume":"142","author":"Olivera","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib55","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1073\/pnas.1601914113","article-title":"Alternative splicing of interleukin-33 and type 2 inflflammation in asthma","volume":"113","author":"Gordon","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2024.e29469_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23071665","article-title":"Interleukin-33: its emerging role in allergic diseases","volume":"23","author":"Ding","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e29469_bib57","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3389\/fimmu.2018.02004","article-title":"Regulatory mechanisms of IL-33-ST2 mediated allergic inflammation","volume":"9","author":"Takatori","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib58","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells","volume":"183","author":"Pr\u00e9fontaine","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib59","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3899\/jrheum.100184","article-title":"Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis","volume":"37","author":"Mu","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/423957","article-title":"Interleukin-33 and inflammatory bowel diseases: lessons from human studies","volume":"2014","author":"Nunes","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.heliyon.2024.e29469_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1189\/jlb.3RU0115-012R","article-title":"The potential role of IL-33\/ST2 signaling in fifibrotic diseases","volume":"98","author":"Gao","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.heliyon.2024.e29469_bib62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cytogfr.2017.09.005","article-title":"Pathophysiology of IL-33 and IL-17 in allergic disorders","volume":"12","author":"Gupta","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.heliyon.2024.e29469_bib63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cytogfr.2019.04.004","article-title":"The role of the IL-33\/ST2 axis in autoimmune disorders: friend or foe?","volume":"50","author":"Liu","year":"2019","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024055002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024055002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:10:31Z","timestamp":1773767431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024055002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024055002"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29469","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of MEFV gene variants, IL-33, and sST2 with the risk of Henoch-Sch\u00f6nlein purpura in children","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29469"}}